GSTP1 and myelodysplastic syndrome: A potent GSTP1 inhibitor, TLK199 (Telik Inc.), has been shown to modulate cell proliferation in human myeloid leukemic cells [58] and is under clinical trial for myelodysplastic syndrome [59].